Reproductive tract OCT

2024-04-08 16:01

Reproductive tract OCT

The innovative and unique catheter design of the reproductive tract OCT catheter launched by Yongstar can construct images in the most natural and suitable sampling state of the tissue, and observe, evaluate and diagnose the three-dimensional microstructure of the lumen wall tissue, especially for the female reproductive tract and uterine lining. Combined with the OCTIS system, this OCT catheter is expected to be widely used in the diagnosis and treatment of a variety of gynecological diseases, such as the early diagnosis of endometrial polyp hyperplasia, fibroma, endometrial cystic disease and other female reproductive tract diseases, as well as the monitoring and prognosis of the effect of surgery or drug treatment, accurate biopsy positioning and even the accurate positioning of the surgical excision area.

Advantages:

1. With ultra-high resolution close to pathological sections, it can penetrate the fine structure of subcutaneous tissue

2. Non-invasive, real-time, accurate, intuitive three-dimensional image

Clinical value:

1. Improve the survival rate of test-tube babies

Evaluate endometrial receptivity, judge the implantation window period of embryo transfer, and greatly improve the success rate of artificial assisted fertility.

2. Uterine cavity assessment and screening

Early detection and screening of cervical and uterine tissue structure.

3. Prognostic monitoring

Monitoring of tissue microstructure changes before and after surgery or drug therapy.

4. Non-destructive testing

It solves the difficult problem of sampling and detection of inconvenient injury of endometrium

Product approval and certification

1. FDA Certification (510K No.K102599)

2. OCT equipment and reproductive tract probes have been approved by the National Innovative medical device Green Channel, and are managed according to Class II medical devices

3. The science and technology survey report of Guangdong Provincial Department of Technology shows that reproductive tract OCT technology fills the global gap.